{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:40:14Z","timestamp":1769942414818,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023368","name":"Eisai Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.drudis.2023.103732","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:24:27Z","timestamp":1691011467000},"page":"103732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing novel therapies for neurodegeneration through an innovative model for industry\u2013academia collaborations: A decade of the Eisai\u2013UCL experience"],"prefix":"10.1016","volume":"28","author":[{"given":"Peter J.","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Kinghorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Staddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K.","family":"Takle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2023.103732_b0005","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.drudis.2013.07.013","article-title":"Models for open innovation in the pharmaceutical industry","volume":"18","author":"Schuhmacher","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2023.103732_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.drudis.2014.10.008","article-title":"Racing to define pharmaceutical R&D external innovation models","volume":"20","author":"Wang","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2023.103732_b0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.drudis.2015.12.008","article-title":"Open innovation in early drug discovery: roadmaps and roadblocks","volume":"21","author":"Reichman","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2023.103732_b0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.glt.2019.05.001","article-title":"Applying open innovation strategies in the context of a regional innovation ecosystem: the case of Janssen Pharmaceuticals","volume":"1","author":"Robaczewska","year":"2019","journal-title":"Glob Transit"},{"key":"10.1016\/j.drudis.2023.103732_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.drudis.2023.103732_b0030","unstructured":"Dementia Consortium. Dementia Consortium website. Accessed 17 May 2023. https:\/\/dementiaconsortium.org\/"},{"key":"10.1016\/j.drudis.2023.103732_b0035","unstructured":"REF 2021. UCL website. Accessed 17 May 2023. https:\/\/www.ucl.ac.uk\/brain-sciences\/research\/ref-2021"},{"key":"10.1016\/j.drudis.2023.103732_b0040","unstructured":"Queen Square Brain Bank for Neurological Disorders. UCL website. Accessed 17 May 2023. https:\/\/www.ucl.ac.uk\/ion\/research\/our-departments\/clinical-and-movement-neurosciences\/centres-and-projects\/queen-square-1"},{"key":"10.1016\/j.drudis.2023.103732_b0045","unstructured":"MRC Prion Unit at UCL, Institute of Prion Diseases. UCL website. Accessed 17 May 2023. https:\/\/www.ucl.ac.uk\/prion\/mrc-prion-unit-ucl-institute-prion-diseases"},{"key":"10.1016\/j.drudis.2023.103732_b0050","unstructured":"UK Parkinson's Disease Consortium (UKPDC). UCL website. Accessed 17 May 2023. https:\/\/www.ucl.ac.uk\/ion\/uk-parkinsons-disease-consortium-ukpdc"},{"key":"10.1016\/j.drudis.2023.103732_b0055","unstructured":"The Leonard Wolfson Experimental Neurology Centre. UCL website. Accessed 17 May 2023. https:\/\/www.ucl.ac.uk\/ion\/research\/research-centres\/leonard-wolfson-experimental-neurology-centre"},{"key":"10.1016\/j.drudis.2023.103732_b0060","unstructured":"National Hospital for Neurology and Neurosurgery. UCLH website. Accessed 17 May 2023. https:\/\/www.uclh.nhs.uk\/our-services\/our-hospitals\/national-hospital-neurology-and-neurosurgery"},{"key":"10.1016\/j.drudis.2023.103732_b0065","unstructured":"UK DRI at UCL. UK DRI website. Accessed 17 May 2023. https:\/\/ukdri.ac.uk\/centres\/ucl"},{"key":"10.1016\/j.drudis.2023.103732_b0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tips.2018.11.004","article-title":"Mitochondrial permeability transition: a molecular lesion with multiple drug targets","volume":"40","author":"Briston","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2023.103732_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/srep37798","article-title":"Identification of ER-000444793, a cyclophilin D-independent inhibitor of mitochondrial permeability transition, using a high-throughput screen in cryopreserved mitochondria","volume":"6","author":"Briston","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103732_b0080","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1038\/s41598-017-10673-8","article-title":"Mitochondrial permeability transition pore: sensitivity to opening and mechanistic dependence on substrate availability","volume":"7","author":"Briston","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103732_b0085","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1042\/BCJ20210508","article-title":"Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches","volume":"478","author":"Tsefou","year":"2021","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2023.103732_b0090","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.3324\/haematol.2019.224717","article-title":"Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug development and patient stratification","volume":"105","author":"Welsh","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.drudis.2023.103732_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129130","article-title":"Identification of pyrimidinyl piperazines as non-iminosugar glucocerebrosidase (GCase) pharmacological chaperones","volume":"81","author":"Hoshikawa","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.drudis.2023.103732_b0100","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","article-title":"Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis","volume":"24","author":"Garcia-Reitboeck","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2023.103732_b0105","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1038\/s41598-021-91207-1","article-title":"Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome","volume":"11","author":"Cosker","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2023.103732_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.drudis.2023.103732_b0115","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1873-3468.13108","article-title":"Tau filaments in neurodegenerative diseases","volume":"592","author":"Goedert","year":"2018","journal-title":"FEBS Lett"},{"key":"10.1016\/j.drudis.2023.103732_b0120","doi-asserted-by":"crossref","first-page":"11714","DOI":"10.1021\/bi000850r","article-title":"Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias","volume":"39","author":"Barghorn","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2023.103732_b0125","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure","volume":"97","author":"von Bergen","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2023.103732_b0130","doi-asserted-by":"crossref","first-page":"48165","DOI":"10.1074\/jbc.M105196200","article-title":"Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure","volume":"276","author":"von Bergen","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2023.103732_b0135","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-150962","article-title":"Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies","volume":"51","author":"Barth\u00e9lemy","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.drudis.2023.103732_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076523","article-title":"Characterization of novel CSF tau and ptau biomarkers for Alzheimer\u2019s disease","volume":"8","author":"Meredith","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2023.103732_b0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jalz.2019.09.060","article-title":"P4-696: Quantification of the tau microtubule binding region (MTBR) in cerebrospinal fluid and subsequent validation of target engagement assay for e2814, a novel anti-tau therapeutic antibody","volume":"15","author":"Horie","year":"2019","journal-title":"Alzheimers. Dement"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623002489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644623002489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:09:25Z","timestamp":1761224965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644623002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1359644623002489"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103732","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing novel therapies for neurodegeneration through an innovative model for industry\u2013academia collaborations: A decade of the Eisai\u2013UCL experience","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2023.103732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103732"}}